Showing 2961-2970 of 8659 results for "".
Physician Spotlight: Meena Singh, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-meena-singh/23939/Muscle Makers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/muscle-makers/23541/The newest body sculpting technologies show promise for building muscle and strength.Diversity and Equity in Dermatology
https://practicaldermatology.com/topics/practice-management/diversity-and-equity-in-dermatology/23456/Aerolase’s Neo Elite 650-Microsecond 1064nm Laser: A New Option for the Treatment of Psoriasis
https://practicaldermatology.com/topics/psoriasis/aerolases-neo-elite-650-microsecond-1064nm-laser-a-new-option-for-the-treatment-of-psoriasis/23204/Physician Spotlight With A. Yasmine Kirkorian, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-with-a-yasmine-kirkorian-md/23082/Physician Spotlight: Richard Odom, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/20702/Revelations and reflections on the pathogenesis and etiology of rosacea.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20924/Where is Dermatology Headed?
https://practicaldermatology.com/topics/psoriasis/where-is-dermatology-headed/18590/Neal Bhatia, MD and Joel Schlessinger, MD sit down as the medical editors of Practical Dermatology® to discuss the future of dermatology in this episode of Derm Insider. They talk about how an increased focus on research in the last few years is leading to new treatments and new understanding aboutKybella Off-Label?
https://practicaldermatology.com/topics/practice-management/kybellaoff-label/21057/Experts weigh in on whether and how Kybella® may be used off-label.Valeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of Imlygic